MedTrace Logo

The Impact of Maternal Microbes on Infant Health Programming

NCT03552939 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-02-09

No results posted yet for this study

Summary

MAMI aims to characterize maternal microbes to be transferred to neonates and determine their function in infant health programming.

Conditions

  • Healthy

Sponsors & Collaborators

  • Fundación para la Investigación del Hospital Clínico de Valencia

    collaborator OTHER

  • Hospital Universitario La Fe

    collaborator OTHER

  • Hospital de Manises

    collaborator OTHER

  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

    collaborator OTHER

  • CS Serreria II

    collaborator UNKNOWN

  • CS La Eliana

    collaborator UNKNOWN

  • Institute of Agrochemistry and Food Technology, National Research Council

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2018-12-31
Completion
2020-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03552939 on ClinicalTrials.gov